Is an advanced age an additive risk factor to the prothrombotic or hypercoagulable state in atrial fibrillation?

International Journal of Cardiology

Volumn 110, Issue 2, 2006, Pages 265-266

  Roldán, Vanessa ^a   Marín, Francisco ^b   García, Amaya ^b   Tello Montoliu, Antonio ^b   Lip, Gregory Y H ^c  

^a Hospital San Vicente (Alicante)   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^c UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DEMOGRAPHY; ELDERLY CARE; EMBOLISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HIGH RISK POPULATION; HUMAN; MALE; PRIORITY JOURNAL; RISK FACTOR; STROKE; STUDENT T TEST; THROMBOSIS;

AGED, 80 AND OVER; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOGEN; HUMANS; INTERLEUKIN-6; LINEAR MODELS; MALE; MULTIVARIATE ANALYSIS; PROTHROMBIN; RISK FACTORS; THROMBOPHILIA; VON WILLEBRAND FACTOR;

EID: 33646813937     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.08.057     Document Type: Article

References (10)

1. Wolf P.A., Abbott R.D., and Kannel W.B. Atrial fibrillation: a major contributor to stroke in the elderly, the Framingham Study. Arch Intern Med 147 (1987) 1561-1564
2. Wolf P.A., Abbott R.D., and Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 2 (1991) 983-988
3. Lip G.Y.H., Lip P.L., Zarifis J., et al. Fibrin D dimmer and betatromboglobulin as a markers of thrombogenesis and platelet activation in atrial fibrillation. Circulation 94 (1996) 425-431
4. Feng D., D'Agostino R.B., Silbershatz H., et al. Haemostatic state and atrial fibrillation (The Framingham Offspring Study). Am J Cardiol 87 (2001) 168-171
5. Roldán V., Marín F., Marco P., et al. Hypofibrinolysis in atrial fibrillation. Am Heart J 136 (1998) 956-960
6. Roldán V., Marín F., Blann A.D., et al. Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation. Eur Heart J 24 (2003) 1373-1380
7. Inoe H., Nozawa T., Okumura K., et al. Prothrombotic activity is increased in patients with nonvalvular atrial fibrillation and risk factors for embolism. Chest 126 (2004) 687-692
8. Conway D.S.G., Heeringa J., Van Der Kuip D.A.M., et al. Atrial fibrillation and the protrombotic state in the elderly. The Rotterdam study. Stroke 34 (2003) 413-417
9. Conway D.S.G., Pearce L.A., Chin B.S.P., et al. Plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 1321 pacientes with nonvalvular atrial fibrillation. Circulation 106 (2002) 1962-1967
10. Conway D.S.G., Pearce L.A., Chin B.S.P., et al. Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation. Circulation 107 (2003) 3141-3145